Induction of apoptosis by a novel copper-based anticancer compound, Casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells

The activity of casiopeina II [Cu(1,4-dimethyl-1,10-phenanthroline)(glycine)NO 3], a novel anticancer agent, was tested in two cell lines, L1210 murine leukaemia, CH1 human ovarian carcinoma, cisplatin-resistant and sensitive. Exposure of the cells to a range of concentrations of casiopeina II indic...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Toxicology in vitro Ročník 14; číslo 1; s. 1 - 5
Hlavní autori:	De Vizcaya-Ruiz, A., Rivero-Muller, A., Ruiz-Ramirez, L., Kass, G.E.N., Kelland, L.R., Orr, R.M., Dobrota, M.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Oxford Elsevier Ltd 01.02.2000 Elsevier Science
Predmet:	Animals Antineoplastic agents Antineoplastic Agents, Phytogenic - pharmacology apoptosis Apoptosis - drug effects Biological and medical sciences cancer chemotherapy casiopeina II Caspases - metabolism CH1 cells copper complexes DNA Fragmentation - drug effects DNA, Neoplasm - analysis DNA, Neoplasm - isolation & purification Enzyme Activation - drug effects Female General aspects Humans L1210 cells Leukemia L1210 - drug therapy Leukemia L1210 - enzymology Leukemia L1210 - pathology Medical sciences Mice Organometallic Compounds - pharmacology Ovarian Neoplasms - drug therapy Ovarian Neoplasms - enzymology Ovarian Neoplasms - pathology Pharmacology. Drug treatments Tumor Cells, Cultured FBS=foetal bovine serum copper complexes PBS=phosphate buffered saline cancer chemotherapy apoptosis Z-VAD-FMK=Z-Val-Ala-DL-Asp-fluoromethylketone Z-DEVD-AFC=Z-Asp-Glu-Val-Asp-7-amino-4-trifluoromethylcoumarin DMEM=Dulbecco's modified Eagle's medium Antineoplastic agent Human Nitrogen heterocycle Rodentia Nitrato complex Organic ligand Cytotoxicity L1210-Leukemia Transition metal Complexes Glycine Copper Complexes In vitro Ovary α-Aminoacid Vertebrata Mammalia Cell line Mouse Cell death Complexes Mixed Animal Mechanism of action Tumor cell Apoptosis
ISSN:	0887-2333, 1879-3177
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	The activity of casiopeina II [Cu(1,4-dimethyl-1,10-phenanthroline)(glycine)NO 3], a novel anticancer agent, was tested in two cell lines, L1210 murine leukaemia, CH1 human ovarian carcinoma, cisplatin-resistant and sensitive. Exposure of the cells to a range of concentrations of casiopeina II indicates that this copper complex kills cells by apoptosis and necrosis. Condensed chromatin and nuclear fragmentation were observed after exposure to casiopeina II. The caspase inhibitor Z-Val-Ala-DL-Asp-fluoromethylketone (Z-VAD-FMK) almost completely inhibited apoptosis induced by cisplatin; however, casiopeina II-induced apoptosis was inhibited only by 50–70%. These data are consistent with caspase activation (measured by Z-Asp-Glu-Val-Asp-7-amino-4-trifluoromethylcoumarin; Z-DEVD-AFC) by casiopeina II and cisplatin and confirm that caspases are activated in the apoptotic cell death induced by casiopeina II. DNA fragmentation was observed in L1210 cells, but not in CH1 cells. No difference in susceptibility to induction of apoptosis by casiopeina II was found between sensitive and cisplatin resistant cells. In this work we show that the novel copper-based antineoplastic agent casiopeina II is highly active against murine and human cancer cell lines, including cell lines resistant to cisplatin.
AbstractList	The activity of casiopeina II [Cu(1,4-dimethyl-1, 10-phenanthroline)(glycine)NO(3)], a novel anticancer agent, was tested in two cell lines, L1210 murine leukaemia, CH1 human ovarian carcinoma, cisplatin-resistant and sensitive. Exposure of the cells to a range of concentrations of casiopeina II indicates that this copper complex kills cells by apoptosis and necrosis. Condensed chromatin and nuclear fragmentation were observed after exposure to casiopeina II. The caspase inhibitor Z-Val-Ala-DL-Asp-fluoromethylketone (Z-VAD-FMK) almost completely inhibited apoptosis induced by cisplatin; however, casiopeina II-induced apoptosis was inhibited only by 50-70%. These data are consistent with caspase activation (measured by Z-Asp-Glu-Val-Asp-7-amino-4-trifluoromethylcoumarin; Z-DEVD-AFC) by casiopeina II and cisplatin and confirm that caspases are activated in the apoptotic cell death induced by casiopeina II. DNA fragmentation was observed in L1210 cells, but not in CH1 cells. No difference in susceptibility to induction of apoptosis by casiopeina II was found between sensitive and cisplatin resistant cells. In this work we show that the novel copper-based antineoplastic agent casiopeina II is highly active against murine and human cancer cell lines, including cell lines resistant to cisplatin.The activity of casiopeina II [Cu(1,4-dimethyl-1, 10-phenanthroline)(glycine)NO(3)], a novel anticancer agent, was tested in two cell lines, L1210 murine leukaemia, CH1 human ovarian carcinoma, cisplatin-resistant and sensitive. Exposure of the cells to a range of concentrations of casiopeina II indicates that this copper complex kills cells by apoptosis and necrosis. Condensed chromatin and nuclear fragmentation were observed after exposure to casiopeina II. The caspase inhibitor Z-Val-Ala-DL-Asp-fluoromethylketone (Z-VAD-FMK) almost completely inhibited apoptosis induced by cisplatin; however, casiopeina II-induced apoptosis was inhibited only by 50-70%. These data are consistent with caspase activation (measured by Z-Asp-Glu-Val-Asp-7-amino-4-trifluoromethylcoumarin; Z-DEVD-AFC) by casiopeina II and cisplatin and confirm that caspases are activated in the apoptotic cell death induced by casiopeina II. DNA fragmentation was observed in L1210 cells, but not in CH1 cells. No difference in susceptibility to induction of apoptosis by casiopeina II was found between sensitive and cisplatin resistant cells. In this work we show that the novel copper-based antineoplastic agent casiopeina II is highly active against murine and human cancer cell lines, including cell lines resistant to cisplatin. The activity of casiopeina II [Cu(1,4-dimethyl-1,10-phenanthroline) (glycine)NO sub(3)], a novel anticancer agent, was tested in two cell lines, L1210 murine leukaemia, CH1 human ovarian carcinoma, cisplatin-resistant and sensitive. Exposure of the cells to a range of concentrations of casiopeina II indicates that this copper complex kills cells by apoptosis and necrosis. Condensed chromatin and nuclear fragmentation were observed after exposure to casiopeina II. The caspase inhibitor Z-Val-Ala-DL-Asp-fluoromethylketone (Z-VAD-FMK) almost completely inhibited apoptosis induced by cisplatin; however, casiopeina II-induced apoptosis was inhibited only by 50-70%. These data are consistent with caspase activation (measured by Z-Asp-Glu-Val-Asp-7-amino-4-trifluoromethylcoumarin; Z-DEVD-AFC) by casiopeina II and cisplatin and confirm that caspases are activated in the apoptotic cell death induced by casiopeina II. DNA fragmentation was observed in L1210 cells, but not in CH1 cells. No difference in susceptibility to induction of apoptosis by casiopeina II was found between sensitive and cisplatin resistant cells. In this work we show that the novel copper-based antineoplastic agent casiopeina II is highly active against murine and human cancer cell lines, including cell lines resistant to cisplatin. The activity of casiopeina II [Cu(1,4-dimethyl-1, 10-phenanthroline)(glycine)NO(3)], a novel anticancer agent, was tested in two cell lines, L1210 murine leukaemia, CH1 human ovarian carcinoma, cisplatin-resistant and sensitive. Exposure of the cells to a range of concentrations of casiopeina II indicates that this copper complex kills cells by apoptosis and necrosis. Condensed chromatin and nuclear fragmentation were observed after exposure to casiopeina II. The caspase inhibitor Z-Val-Ala-DL-Asp-fluoromethylketone (Z-VAD-FMK) almost completely inhibited apoptosis induced by cisplatin; however, casiopeina II-induced apoptosis was inhibited only by 50-70%. These data are consistent with caspase activation (measured by Z-Asp-Glu-Val-Asp-7-amino-4-trifluoromethylcoumarin; Z-DEVD-AFC) by casiopeina II and cisplatin and confirm that caspases are activated in the apoptotic cell death induced by casiopeina II. DNA fragmentation was observed in L1210 cells, but not in CH1 cells. No difference in susceptibility to induction of apoptosis by casiopeina II was found between sensitive and cisplatin resistant cells. In this work we show that the novel copper-based antineoplastic agent casiopeina II is highly active against murine and human cancer cell lines, including cell lines resistant to cisplatin. The activity of casiopeina II [Cu(1,4-dimethyl-1,10-phenanthroline)(glycine)NO 3], a novel anticancer agent, was tested in two cell lines, L1210 murine leukaemia, CH1 human ovarian carcinoma, cisplatin-resistant and sensitive. Exposure of the cells to a range of concentrations of casiopeina II indicates that this copper complex kills cells by apoptosis and necrosis. Condensed chromatin and nuclear fragmentation were observed after exposure to casiopeina II. The caspase inhibitor Z-Val-Ala-DL-Asp-fluoromethylketone (Z-VAD-FMK) almost completely inhibited apoptosis induced by cisplatin; however, casiopeina II-induced apoptosis was inhibited only by 50–70%. These data are consistent with caspase activation (measured by Z-Asp-Glu-Val-Asp-7-amino-4-trifluoromethylcoumarin; Z-DEVD-AFC) by casiopeina II and cisplatin and confirm that caspases are activated in the apoptotic cell death induced by casiopeina II. DNA fragmentation was observed in L1210 cells, but not in CH1 cells. No difference in susceptibility to induction of apoptosis by casiopeina II was found between sensitive and cisplatin resistant cells. In this work we show that the novel copper-based antineoplastic agent casiopeina II is highly active against murine and human cancer cell lines, including cell lines resistant to cisplatin.
Author	Kass, G.E.N. Rivero-Muller, A. Kelland, L.R. Dobrota, M. Orr, R.M. De Vizcaya-Ruiz, A. Ruiz-Ramirez, L.
Author_xml	– sequence: 1 givenname: A. surname: De Vizcaya-Ruiz fullname: De Vizcaya-Ruiz, A. organization: School of Biological Sciences, University of Surrey, Guildford, Surrey GU2 5XH, UK – sequence: 2 givenname: A. surname: Rivero-Muller fullname: Rivero-Muller, A. organization: School of Biological Sciences, University of Surrey, Guildford, Surrey GU2 5XH, UK – sequence: 3 givenname: L. surname: Ruiz-Ramirez fullname: Ruiz-Ramirez, L. organization: Facultad de Quı́mica, UNAM, México D.F. 04510, Mexico – sequence: 4 givenname: G.E.N. surname: Kass fullname: Kass, G.E.N. organization: School of Biological Sciences, University of Surrey, Guildford, Surrey GU2 5XH, UK – sequence: 5 givenname: L.R. surname: Kelland fullname: Kelland, L.R. organization: CRC Centre For Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK – sequence: 6 givenname: R.M. surname: Orr fullname: Orr, R.M. organization: CRC Centre For Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK – sequence: 7 givenname: M. surname: Dobrota fullname: Dobrota, M. organization: School of Biological Sciences, University of Surrey, Guildford, Surrey GU2 5XH, UK
BackLink	http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1288441$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/10699355$$D View this record in MEDLINE/PubMed
BookMark	eNqFkcuKFDEUhoOMOD2jj6BkIaIwpblUVSq4EGnUaWhwocLswsmlMFqVlElVw7yGT2x6ur3gplcHwvf_OZzvAp2FGBxCjyl5SQltX30iXScqxjl_LuULQkjHqpt7aEU7IStOhThDqz_IObrI-VuBmo6RB-icklZK3jQr9HMT7GJmHwOOPYYpTnPMPmN9iwGHuHMDNnGaXKo0ZGcxhNkbCMal8j5OcQn2Cq8h-zg5HwBvNlfYB7yljBI8LskHhwe3fAc3eihpi9fXFH9dRigf7iD5Mg0k40McARs3DPkhut_DkN2j47xEX96_-7y-rrYfP2zWb7eVqRmdq7ZmrG8oiJ5JrW3T96AZr7WWUGvDBdfQ1XXLJbXO8rYn2trWUNk1rhMCHL9Ezw69U4o_FpdnNfq83wCCi0tWglLaNkKeBKloCJOMFvDJEVz06Kyakh8h3arf5y7A0yMA2cDQp3JJn_9yrCsr73uaA2ZSzDm5_p8mtbev7uyrvVolpbqzr25K7vV_OeNn2MudE_jhZPrNIe3K0XfeJZWNd0W19cmZWdnoTzT8AtteyYs
CODEN	TIVIEQ
CitedBy_id	crossref_primary_10_1016_j_jinorgbio_2008_10_006 crossref_primary_10_1016_j_jddst_2018_07_004 crossref_primary_10_1016_j_jinorgbio_2007_02_002 crossref_primary_10_3109_14756360902827653 crossref_primary_10_1039_c9mt00182d crossref_primary_10_1080_00958972_2014_938064 crossref_primary_10_1016_j_jinorgbio_2013_09_014 crossref_primary_10_1080_00958972_2013_857015 crossref_primary_10_1016_j_jinorgbio_2016_07_001 crossref_primary_10_1016_S0006_2952_03_00212_0 crossref_primary_10_1016_j_jscs_2011_11_020 crossref_primary_10_1186_1471_2407_12_156 crossref_primary_10_1016_j_jinorgbio_2012_07_009 crossref_primary_10_1007_s12011_013_9707_7 crossref_primary_10_1593_neo_04607 crossref_primary_10_1016_j_taap_2005_06_023 crossref_primary_10_1021_ic101791r crossref_primary_10_1002_ejic_200400357 crossref_primary_10_1016_j_jinorgbio_2022_111772 crossref_primary_10_1016_j_jscs_2011_01_016 crossref_primary_10_1016_j_jinorgbio_2021_111634 crossref_primary_10_1007_s00204_012_0809_3 crossref_primary_10_1002_ardp_200700021 crossref_primary_10_1016_j_jinorgbio_2019_110926 crossref_primary_10_1016_j_leukres_2016_11_001 crossref_primary_10_1016_S0887_2333_02_00043_7 crossref_primary_10_1016_j_tiv_2007_11_011 crossref_primary_10_1007_s00706_021_02742_6 crossref_primary_10_1007_s10534_011_9477_7 crossref_primary_10_1016_j_ica_2006_04_007 crossref_primary_10_1016_j_etap_2014_03_003 crossref_primary_10_1007_s10534_016_9983_8 crossref_primary_10_1111_j_1742_7843_2007_00038_x crossref_primary_10_1016_j_jinorgbio_2016_11_007 crossref_primary_10_1016_j_poly_2025_117723 crossref_primary_10_1039_C4DT02700K crossref_primary_10_1023_A_1022577420708 crossref_primary_10_1016_j_etap_2016_11_008 crossref_primary_10_1016_j_cbi_2006_12_002 crossref_primary_10_1016_j_jinorgbio_2011_03_012 crossref_primary_10_1016_j_molstruc_2020_129035 crossref_primary_10_1002_mnfr_200700470 crossref_primary_10_1016_j_inoche_2011_06_025 crossref_primary_10_1155_2013_872940 crossref_primary_10_1002_chem_201402775 crossref_primary_10_1016_j_inoche_2016_07_008 crossref_primary_10_1002_ejic_201700416 crossref_primary_10_1002_slct_202203242 crossref_primary_10_1002_smll_202412462 crossref_primary_10_1080_01480545_2016_1190738 crossref_primary_10_1038_s41392_025_02192_0 crossref_primary_10_1016_j_ejmech_2012_08_019 crossref_primary_10_1039_D2RA03346A crossref_primary_10_1016_j_ica_2014_05_041 crossref_primary_10_1016_j_tiv_2003_08_011 crossref_primary_10_1016_j_jinorgbio_2012_01_010 crossref_primary_10_1016_j_cbi_2015_02_004 crossref_primary_10_1016_j_jinorgbio_2016_06_005 crossref_primary_10_1016_j_poly_2009_04_029 crossref_primary_10_1007_s10534_007_9089_4 crossref_primary_10_1016_j_tiv_2011_02_007 crossref_primary_10_1016_j_poly_2007_08_041 crossref_primary_10_1016_j_poly_2024_117064 crossref_primary_10_1016_j_ica_2011_11_021 crossref_primary_10_1371_journal_pone_0054664 crossref_primary_10_1002_ejic_201601199 crossref_primary_10_1007_s10534_018_0079_5 crossref_primary_10_1016_j_pharep_2016_07_011 crossref_primary_10_1016_S1570_0232_03_00226_5 crossref_primary_10_1007_s00894_020_04453_x crossref_primary_10_1016_j_poly_2015_10_034 crossref_primary_10_2217_nnm_2016_0086 crossref_primary_10_1016_j_jinorgbio_2009_05_008 crossref_primary_10_1046_j_1471_4159_2003_02029_x crossref_primary_10_1016_j_jinorgbio_2011_01_004 crossref_primary_10_1016_j_poly_2008_08_022 crossref_primary_10_1093_nar_gkv467 crossref_primary_10_1016_j_arabjc_2016_04_013 crossref_primary_10_22207_JPAM_11_1_19 crossref_primary_10_3390_ijms25168803 crossref_primary_10_1016_j_jinorgbio_2005_03_013 crossref_primary_10_1016_j_jcat_2020_07_016 crossref_primary_10_1016_j_poly_2011_07_022 crossref_primary_10_3390_pharmaceutics15041314 crossref_primary_10_1016_j_ica_2020_119961 crossref_primary_10_1016_j_jinorgbio_2015_06_019 crossref_primary_10_1080_00958972_2014_915966 crossref_primary_10_1016_j_compbiolchem_2018_11_021 crossref_primary_10_1016_j_tiv_2011_05_008 crossref_primary_10_1016_j_tox_2013_08_018 crossref_primary_10_1089_dna_2011_1592 crossref_primary_10_1080_00958972_2014_926337 crossref_primary_10_1016_j_ejphar_2013_09_038 crossref_primary_10_1016_j_ejmech_2017_01_045 crossref_primary_10_1016_j_jinorgbio_2023_112324 crossref_primary_10_1016_j_tiv_2016_02_008 crossref_primary_10_1080_15287394_2017_1326072 crossref_primary_10_1016_j_carres_2010_07_007 crossref_primary_10_1007_s12039_016_1050_z crossref_primary_10_1093_mtomcs_mfae001 crossref_primary_10_1007_s00280_006_0364_9 crossref_primary_10_1111_j_1472_8206_2012_01075_x crossref_primary_10_1007_s00775_012_0912_1 crossref_primary_10_1016_j_ica_2020_119542
Cites_doi	10.1016/S0167-5699(97)80014-X 10.1139/o97-043 10.1038/bjc.1996.486 10.1016/0968-0004(93)90042-L 10.1016/0162-0134(93)85435-B 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J 10.1126/science.281.5381.1305 10.1093/emboj/17.1.37 10.1007/s002800050413 10.1006/excr.1995.1281 10.1016/0162-0134(95)97313-F 10.1038/34214 10.1007/BF00193472 10.1038/376037a0 10.1007/978-94-011-1252-9 10.1007/s000180050171 10.1038/bjc.1989.33 10.1126/science.281.5381.1309 10.1002/j.1460-2075.1993.tb06042.x 10.1038/bjc.1994.14 10.1016/S0962-8924(98)01273-2 10.1002/hep.510270624 10.1016/S0014-5793(97)00507-3
ContentType	Journal Article
Copyright	2000 Elsevier Science Ltd 2000 INIST-CNRS
Copyright_xml	– notice: 2000 Elsevier Science Ltd – notice: 2000 INIST-CNRS
DBID	AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7U7 C1K 7X8
DOI	10.1016/S0887-2333(99)00082-X
DatabaseName	CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic Toxicology Abstracts MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Chemistry Public Health Pharmacy, Therapeutics, & Pharmacology
EISSN	1879-3177
EndPage	5
ExternalDocumentID	10699355 1288441 10_1016_S0887_2333_99_00082_X S088723339900082X
Genre	Research Support, Non-U.S. Gov't Journal Article
GroupedDBID	--- --K --M .~1 0R~ 123 1B1 1RT 1~. 1~5 29Q 4.4 457 4G. 53G 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATCM AAXUO ABFRF ABFYP ABJNI ABLST ABMAC ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHEUO AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AKIFW ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLECG BLXMC CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMT HVGLF HZ~ IHE J1W KCYFY KOM M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SDF SDG SDP SES SEW SPCBC SPT SSJ SSP SSZ T5K UNMZH WUQ ZXP ~G- 9DU AATTM AAXKI AAYWO AAYXX ABWVN ACLOT ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGQPQ AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP CITATION EFKBS ~HD AGCQF AGRNS BNPGV IQODW SSH CGR CUY CVF ECM EIF NPM 7U7 C1K 7X8
ID	FETCH-LOGICAL-c421t-6422f51a7f29bbd5ffab234bb9a4bc373ba8446391ded36f0bdd6c1985e877ae3
ISICitedReferencesCount	122
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000085523900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0887-2333
IngestDate	Thu Oct 02 11:22:51 EDT 2025 Mon Oct 06 17:37:55 EDT 2025 Wed Feb 19 01:41:35 EST 2025 Mon Jul 21 09:13:49 EDT 2025 Tue Nov 18 21:38:43 EST 2025 Sat Nov 29 03:07:11 EST 2025 Fri Feb 23 02:26:57 EST 2024
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	FBS=foetal bovine serum copper complexes PBS=phosphate buffered saline cancer chemotherapy apoptosis Z-VAD-FMK=Z-Val-Ala-DL-Asp-fluoromethylketone Z-DEVD-AFC=Z-Asp-Glu-Val-Asp-7-amino-4-trifluoromethylcoumarin DMEM=Dulbecco's modified Eagle's medium Antineoplastic agent Human Nitrogen heterocycle Rodentia Nitrato complex Organic ligand Cytotoxicity L1210-Leukemia Transition metal Complexes Glycine Copper Complexes In vitro Ovary α-Aminoacid Vertebrata Mammalia Cell line Mouse Cell death Complexes Mixed Animal Mechanism of action Tumor cell Apoptosis
Language	English
License	https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c421t-6422f51a7f29bbd5ffab234bb9a4bc373ba8446391ded36f0bdd6c1985e877ae3
Notes	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2
PMID	10699355
PQID	17502921
PQPubID	23462
PageCount	5
ParticipantIDs	proquest_miscellaneous_71116579 proquest_miscellaneous_17502921 pubmed_primary_10699355 pascalfrancis_primary_1288441 crossref_primary_10_1016_S0887_2333_99_00082_X crossref_citationtrail_10_1016_S0887_2333_99_00082_X elsevier_sciencedirect_doi_10_1016_S0887_2333_99_00082_X
PublicationCentury	2000
PublicationDate	2000-02-01
PublicationDateYYYYMMDD	2000-02-01
PublicationDate_xml	– month: 02 year: 2000 text: 2000-02-01 day: 01
PublicationDecade	2000
PublicationPlace	Oxford
PublicationPlace_xml	– name: Oxford – name: England
PublicationTitle	Toxicology in vitro
PublicationTitleAlternate	Toxicol In Vitro
PublicationYear	2000
Publisher	Elsevier Ltd Elsevier Science
Publisher_xml	– name: Elsevier Ltd – name: Elsevier Science
References	Solans, Ruı́z-Ramı́rez, Martı́nez, Gasque, Moreno-Esparza (BIB26) 1993; C49 Fricker P. S. (1994) Metal compounds in Cancer Therapy. In Barge, Willemze, Vandenabeele, Fiers, Beyaert (BIB3) 1997; 409 Huschtscha, Bartier, Malstrom, Tattersal (BIB12) 1995; 6 Green, Reed (BIB10) 1998; 281 Nicholson, Ali, Thornberry, Vaillancourt, Ding, Gallant, Gareau, Griffin, Labelle, Lazebnik, Munday, Raju, Smulson, Yamin, Yu, Miller (BIB18) 1995; 376 O'Neill, Ormerod, Robertson, Titley, Cumber-Walsweer, Kelland (BIB20) 1996; 74 Kroemer, Zamzami, Susin (BIB17) 1997; 18 Sakahira, Enari, Nagata (BIB25) 1998; 391 Köpf-Maier (BIB16) 1994; 47 Bossy-Wetzel, Newmeyer, Green (BIB5) 1998; 17 Ruiz-Ramirez, Gracia-Mora, De La, Sumano, Gomez, Arenas, Gomez, Pimentel, Cruces (BIB24) 1993; 51 Duriez, Shah (BIB7) 1997; 75 Kerr, Winterford, Harmon (BIB15) 1994; 73 Allen, Cluck, Agrwal (BIB1) 1998; 54 Ruiz-Ramirez, De La, Gracia-Mora, Mendoza, Perez, Ferrer-Sueta, Tovar, Breña, Gutierrez, Cruces-Martinez (BIB23) 1995; 59 Collins, Lopez-Rivas (BIB6) 1993; 18 ed. R. A. Lockshin, Z. Zakeri and J. L. Tilly, pp. 250–260. Wiley-Liss, New York Ormerod, Orr, Peacock (BIB22) 1994; 69 Benitez-Bribiesca L. (1998) Assessment of apoptosis in tumour growth: importance in clinical oncology and cancer therapy. In Green, Kroemer (BIB9) 1998; 8 Oberhammer, Wilson, Dive, Morris, Hickman, Wakeling, Walker, Sokorska (BIB19) 1993; 12 Jones, Johnson, Buck, Dobrota, Hinton, Chow, Kass (BIB13) 1998; 27 Ashekanzi, Dixit (BIB2) 1998; 281 Ormerod, O'Neill, Robertson, Kelland, Harrap (BIB21) 1996; 37 Horwich (BIB11) 1989; 59 Weis, Schlegel, Kass, Hölmstrom, Peters, Eriksson, Orrenius, Chow (BIB27) 1995; 219 Kaufmann, Desnoyers, Ottaviano, Davidson, Poirier (BIB14) 1993; 53 pp. 10–15. Chapman and Hall, London Ruiz-Ramirez (10.1016/S0887-2333(99)00082-X_BIB23) 1995; 59 Barge (10.1016/S0887-2333(99)00082-X_BIB3) 1997; 409 Duriez (10.1016/S0887-2333(99)00082-X_BIB7) 1997; 75 Ormerod (10.1016/S0887-2333(99)00082-X_BIB22) 1994; 69 Oberhammer (10.1016/S0887-2333(99)00082-X_BIB19) 1993; 12 Kaufmann (10.1016/S0887-2333(99)00082-X_BIB14) 1993; 53 Weis (10.1016/S0887-2333(99)00082-X_BIB27) 1995; 219 Jones (10.1016/S0887-2333(99)00082-X_BIB13) 1998; 27 Kroemer (10.1016/S0887-2333(99)00082-X_BIB17) 1997; 18 Huschtscha (10.1016/S0887-2333(99)00082-X_BIB12) 1995; 6 10.1016/S0887-2333(99)00082-X_BIB4 Bossy-Wetzel (10.1016/S0887-2333(99)00082-X_BIB5) 1998; 17 Ormerod (10.1016/S0887-2333(99)00082-X_BIB21) 1996; 37 Ashekanzi (10.1016/S0887-2333(99)00082-X_BIB2) 1998; 281 Kerr (10.1016/S0887-2333(99)00082-X_BIB15) 1994; 73 Green (10.1016/S0887-2333(99)00082-X_BIB10) 1998; 281 10.1016/S0887-2333(99)00082-X_BIB8 Nicholson (10.1016/S0887-2333(99)00082-X_BIB18) 1995; 376 Ruiz-Ramirez (10.1016/S0887-2333(99)00082-X_BIB24) 1993; 51 Green (10.1016/S0887-2333(99)00082-X_BIB9) 1998; 8 Sakahira (10.1016/S0887-2333(99)00082-X_BIB25) 1998; 391 Köpf-Maier (10.1016/S0887-2333(99)00082-X_BIB16) 1994; 47 Horwich (10.1016/S0887-2333(99)00082-X_BIB11) 1989; 59 Allen (10.1016/S0887-2333(99)00082-X_BIB1) 1998; 54 Collins (10.1016/S0887-2333(99)00082-X_BIB6) 1993; 18 Solans (10.1016/S0887-2333(99)00082-X_BIB26) 1993; C49 O'Neill (10.1016/S0887-2333(99)00082-X_BIB20) 1996; 74
References_xml	– volume: 376 start-page: 37 year: 1995 end-page: 43 ident: BIB18 article-title: Identification and inhibition of ICE/CED-3 protease necessary for mammalian apoptosis publication-title: Nature – volume: 74 start-page: 1037 year: 1996 end-page: 1045 ident: BIB20 article-title: Apoptotic and non-apoptotic cell death induced by publication-title: British Journal of Cancer – volume: C49 start-page: 890 year: 1993 end-page: 893 ident: BIB26 article-title: Mixed chelate complexes publication-title: Acta Crystallographica – volume: 47 start-page: 1 year: 1994 end-page: 16 ident: BIB16 article-title: Complexes of metals other than platinum as antitumour agents publication-title: European Journal of Clinical Pharmacology – reference: , ed. R. A. Lockshin, Z. Zakeri and J. L. Tilly, pp. 250–260. Wiley-Liss, New York – volume: 409 start-page: 207 year: 1997 end-page: 210 ident: BIB3 article-title: Differential involvement of caspases in apoptosis of myeloid leukaemic cells induced by chemotherapy versus growth withdrawal publication-title: FEBS Letters – volume: 75 start-page: 337 year: 1997 end-page: 349 ident: BIB7 article-title: Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death publication-title: Biochemistry and Cell Biology – reference: Fricker P. S. (1994) Metal compounds in Cancer Therapy. In – volume: 391 start-page: 96 year: 1998 end-page: 99 ident: BIB25 article-title: Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis publication-title: Nature – volume: 27 start-page: 1632 year: 1998 end-page: 1642 ident: BIB13 article-title: Fas-mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases publication-title: Hepatology – volume: 54 start-page: 427 year: 1998 end-page: 445 ident: BIB1 article-title: Mechanisms controlling cellular suicide: role of Bcl-2 and caspases publication-title: Cellular and Molecular Life Sciences – volume: 59 start-page: 2 year: 1995 end-page: 3207 ident: BIB23 article-title: Casiopeinas, metal-based drugs a new class of antineoplastic and genotoxic compounds publication-title: Journal of Inorganic Biochemistry – volume: 51 start-page: 1 year: 1993 end-page: 2406 ident: BIB24 article-title: Cytostatic, Mutagenic, Antineoplastic activities and preliminary toxicity of copper (II) new drugs: casiopeinas I, II, III publication-title: Journal of Inorganic Biochemistry – volume: 59 start-page: 156 year: 1989 end-page: 159 ident: BIB11 article-title: Germ cell tumour chemotherapy publication-title: British Journal of Cancer – volume: 6 start-page: 585 year: 1995 end-page: 593 ident: BIB12 article-title: Cell death by apoptosis following anticancer drug treatment publication-title: International Journal of Oncology – volume: 219 start-page: 699 year: 1995 end-page: 708 ident: BIB27 article-title: Cellular events in Fas/APO-1 mediated apoptosis in JURKAT T lymphocytes publication-title: Experimental Cell Research – volume: 37 start-page: 463 year: 1996 end-page: 471 ident: BIB21 publication-title: Cancer Chemotherapy and Pharmacology – volume: 18 start-page: 44 year: 1997 end-page: 51 ident: BIB17 article-title: Mitochondrial control of apoptosis publication-title: Immunology Today – volume: 69 start-page: 93 year: 1994 end-page: 100 ident: BIB22 article-title: The role of apoptosis in cell killing by cisplatin: a flow cytometric study publication-title: British Journal of Cancer – volume: 18 start-page: 307 year: 1993 end-page: 309 ident: BIB6 article-title: The control of apoptosis in mammalian cells publication-title: Trends in Biochemical Sciences – volume: 281 start-page: 1305 year: 1998 end-page: 1308 ident: BIB2 article-title: Death receptors: signalling and modulation publication-title: Science – volume: 281 start-page: 1309 year: 1998 end-page: 1312 ident: BIB10 article-title: Mitochondria and apoptosis publication-title: Science – volume: 73 start-page: 2013 year: 1994 end-page: 2026 ident: BIB15 article-title: Apoptosis, its significance in cancer and cancer therapy publication-title: Cancer – volume: 12 start-page: 3679 year: 1993 end-page: 3684 ident: BIB19 article-title: Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation publication-title: EMBO Journal – volume: 8 start-page: 267 year: 1998 end-page: 277 ident: BIB9 article-title: The central executioners of apoptosis: caspases or mitochondria? publication-title: Trends in Cell Biology – volume: 53 start-page: 3976 year: 1993 end-page: 3985 ident: BIB14 article-title: Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis publication-title: Cancer Research – reference: Benitez-Bribiesca L. (1998) Assessment of apoptosis in tumour growth: importance in clinical oncology and cancer therapy. In – volume: 17 start-page: 37 year: 1998 end-page: 49 ident: BIB5 article-title: Mitochondrial cytochrome publication-title: EMBO Journal – reference: , pp. 10–15. Chapman and Hall, London – volume: 18 start-page: 44 year: 1997 ident: 10.1016/S0887-2333(99)00082-X_BIB17 article-title: Mitochondrial control of apoptosis publication-title: Immunology Today doi: 10.1016/S0167-5699(97)80014-X – volume: 75 start-page: 337 year: 1997 ident: 10.1016/S0887-2333(99)00082-X_BIB7 article-title: Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death publication-title: Biochemistry and Cell Biology doi: 10.1139/o97-043 – volume: 74 start-page: 1037 year: 1996 ident: 10.1016/S0887-2333(99)00082-X_BIB20 article-title: Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine (cyclohexylamine) dihydroxodichloroplatinum (IV) complex publication-title: British Journal of Cancer doi: 10.1038/bjc.1996.486 – volume: 18 start-page: 307 year: 1993 ident: 10.1016/S0887-2333(99)00082-X_BIB6 article-title: The control of apoptosis in mammalian cells publication-title: Trends in Biochemical Sciences doi: 10.1016/0968-0004(93)90042-L – volume: 51 start-page: 1 year: 1993 ident: 10.1016/S0887-2333(99)00082-X_BIB24 article-title: Cytostatic, Mutagenic, Antineoplastic activities and preliminary toxicity of copper (II) new drugs: casiopeinas I, II, III publication-title: Journal of Inorganic Biochemistry doi: 10.1016/0162-0134(93)85435-B – volume: 73 start-page: 2013 year: 1994 ident: 10.1016/S0887-2333(99)00082-X_BIB15 article-title: Apoptosis, its significance in cancer and cancer therapy publication-title: Cancer doi: 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J – volume: 281 start-page: 1305 year: 1998 ident: 10.1016/S0887-2333(99)00082-X_BIB2 article-title: Death receptors: signalling and modulation publication-title: Science doi: 10.1126/science.281.5381.1305 – volume: 17 start-page: 37 year: 1998 ident: 10.1016/S0887-2333(99)00082-X_BIB5 article-title: Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization publication-title: EMBO Journal doi: 10.1093/emboj/17.1.37 – volume: 37 start-page: 463 year: 1996 ident: 10.1016/S0887-2333(99)00082-X_BIB21 article-title: Cis-diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines publication-title: Cancer Chemotherapy and Pharmacology doi: 10.1007/s002800050413 – volume: 6 start-page: 585 year: 1995 ident: 10.1016/S0887-2333(99)00082-X_BIB12 article-title: Cell death by apoptosis following anticancer drug treatment in vitro publication-title: International Journal of Oncology – volume: 219 start-page: 699 year: 1995 ident: 10.1016/S0887-2333(99)00082-X_BIB27 article-title: Cellular events in Fas/APO-1 mediated apoptosis in JURKAT T lymphocytes publication-title: Experimental Cell Research doi: 10.1006/excr.1995.1281 – volume: 59 start-page: 2 year: 1995 ident: 10.1016/S0887-2333(99)00082-X_BIB23 article-title: Casiopeinas, metal-based drugs a new class of antineoplastic and genotoxic compounds publication-title: Journal of Inorganic Biochemistry doi: 10.1016/0162-0134(95)97313-F – volume: 391 start-page: 96 year: 1998 ident: 10.1016/S0887-2333(99)00082-X_BIB25 article-title: Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis publication-title: Nature doi: 10.1038/34214 – volume: 47 start-page: 1 year: 1994 ident: 10.1016/S0887-2333(99)00082-X_BIB16 article-title: Complexes of metals other than platinum as antitumour agents publication-title: European Journal of Clinical Pharmacology doi: 10.1007/BF00193472 – volume: 376 start-page: 37 year: 1995 ident: 10.1016/S0887-2333(99)00082-X_BIB18 article-title: Identification and inhibition of ICE/CED-3 protease necessary for mammalian apoptosis publication-title: Nature doi: 10.1038/376037a0 – volume: 53 start-page: 3976 year: 1993 ident: 10.1016/S0887-2333(99)00082-X_BIB14 article-title: Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis publication-title: Cancer Research – ident: 10.1016/S0887-2333(99)00082-X_BIB4 – volume: C49 start-page: 890 year: 1993 ident: 10.1016/S0887-2333(99)00082-X_BIB26 article-title: Mixed chelate complexes. Structures of L-alaninato(aqua)(4,7-diphenyl-1,10-phenenthroline)copper(II)nitrate monohydrate and Aqua(4,7-dimethyl-1,10-phenenthroline)(glycinato)(nitrato)copper(II) monohydrate publication-title: Acta Crystallographica – ident: 10.1016/S0887-2333(99)00082-X_BIB8 doi: 10.1007/978-94-011-1252-9 – volume: 54 start-page: 427 year: 1998 ident: 10.1016/S0887-2333(99)00082-X_BIB1 article-title: Mechanisms controlling cellular suicide: role of Bcl-2 and caspases publication-title: Cellular and Molecular Life Sciences doi: 10.1007/s000180050171 – volume: 59 start-page: 156 year: 1989 ident: 10.1016/S0887-2333(99)00082-X_BIB11 article-title: Germ cell tumour chemotherapy publication-title: British Journal of Cancer doi: 10.1038/bjc.1989.33 – volume: 281 start-page: 1309 year: 1998 ident: 10.1016/S0887-2333(99)00082-X_BIB10 article-title: Mitochondria and apoptosis publication-title: Science doi: 10.1126/science.281.5381.1309 – volume: 12 start-page: 3679 year: 1993 ident: 10.1016/S0887-2333(99)00082-X_BIB19 article-title: Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation publication-title: EMBO Journal doi: 10.1002/j.1460-2075.1993.tb06042.x – volume: 69 start-page: 93 year: 1994 ident: 10.1016/S0887-2333(99)00082-X_BIB22 article-title: The role of apoptosis in cell killing by cisplatin: a flow cytometric study publication-title: British Journal of Cancer doi: 10.1038/bjc.1994.14 – volume: 8 start-page: 267 year: 1998 ident: 10.1016/S0887-2333(99)00082-X_BIB9 article-title: The central executioners of apoptosis: caspases or mitochondria? publication-title: Trends in Cell Biology doi: 10.1016/S0962-8924(98)01273-2 – volume: 27 start-page: 1632 year: 1998 ident: 10.1016/S0887-2333(99)00082-X_BIB13 article-title: Fas-mediated apoptosis in mouse hepatocytes involves the processing and activation of caspases publication-title: Hepatology doi: 10.1002/hep.510270624 – volume: 409 start-page: 207 year: 1997 ident: 10.1016/S0887-2333(99)00082-X_BIB3 article-title: Differential involvement of caspases in apoptosis of myeloid leukaemic cells induced by chemotherapy versus growth withdrawal publication-title: FEBS Letters doi: 10.1016/S0014-5793(97)00507-3
SSID	ssj0005820
Score	1.932575
Snippet	The activity of casiopeina II [Cu(1,4-dimethyl-1,10-phenanthroline)(glycine)NO 3], a novel anticancer agent, was tested in two cell lines, L1210 murine... The activity of casiopeina II [Cu(1,4-dimethyl-1, 10-phenanthroline)(glycine)NO(3)], a novel anticancer agent, was tested in two cell lines, L1210 murine... The activity of casiopeina II [Cu(1,4-dimethyl-1,10-phenanthroline) (glycine)NO sub(3)], a novel anticancer agent, was tested in two cell lines, L1210 murine...
SourceID	proquest pubmed pascalfrancis crossref elsevier
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	1
SubjectTerms	Animals Antineoplastic agents Antineoplastic Agents, Phytogenic - pharmacology apoptosis Apoptosis - drug effects Biological and medical sciences cancer chemotherapy casiopeina II Caspases - metabolism CH1 cells copper complexes DNA Fragmentation - drug effects DNA, Neoplasm - analysis DNA, Neoplasm - isolation & purification Enzyme Activation - drug effects Female General aspects Humans L1210 cells Leukemia L1210 - drug therapy Leukemia L1210 - enzymology Leukemia L1210 - pathology Medical sciences Mice Organometallic Compounds - pharmacology Ovarian Neoplasms - drug therapy Ovarian Neoplasms - enzymology Ovarian Neoplasms - pathology Pharmacology. Drug treatments Tumor Cells, Cultured
Title	Induction of apoptosis by a novel copper-based anticancer compound, Casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells
URI	https://dx.doi.org/10.1016/S0887-2333(99)00082-X https://www.ncbi.nlm.nih.gov/pubmed/10699355 https://www.proquest.com/docview/17502921 https://www.proquest.com/docview/71116579
Volume	14
WOSCitedRecordID	wos000085523900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1879-3177 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0005820 issn: 0887-2333 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZ2QQJpQjAYFNjwA5tAqSHXJX6cqk4rKmOaOtS3yE4cKaJNQtNW3X4G_4P_yHGcxJtgDB54SSvHF8Xns32O7fMdhN4kru-xyBbEcSyPuDQRhMVBTITPbQHqCejQFc_s0D89DcZjera29qPxhVlO_CwLVita_FdRQxoIW7rO_oO420ohAf6D0OEJYofnXwleBuOIGj2QFXkxzyXpCKiZzMjypZB8IEUhZkQuYJKoVe5mg-hn1fVyGWVJdnvEyjQvRJoxYzCQCWlmDCUNmDGV-_PCmIjFVyamyqfL6J1Ydbi_fAnWN_xGMkhRlk-ZIc8GyutK8ChfpZHifoJal-l8lrf6tDC-pFcRu2TkfJFe3dhsPZdXSHLyadF4L-o3kJWcsylM31fak0IuI6yOCV87XDTbG2ZzI_rGLGg7ii2jnbLdX6Cp5l_rt6uC2qAo26r2pZW5b9NKASIrvRQ2x_-nn8Pji-EwHPXHo4PiG5FByuRhfh2xZR1t2r5HYRLdPBr0xx_1naJA8YA2DWmXsQ-69beUvqtbvk0Z2ipYCUM0UbFVbjd-KiVo9Ag9rK0XfKRQ9xitiWwb3e81QQO30cGZokK_7OKR9uwru_gAn2mSdMi4pfaLsXKDe4K-t7DFeYJb2GJ-iRmuYIuvwxZr2OIGtl2sQYsHgy5OM1xBFivI4hayUDrGAFlcQRbXkMUtZHEF2afo4rg_6p2QOl4IiVzbmhMwpe3Es5if2JTz2EsSxm3H5Zwyl0eO73AWuC6o5FYsYucwMXkcH0YWDTwR-D4Tzg7ayPJMPEeYBzaV3JosSoRLTUF5bJqMm7EXOGCk8A5yG8GFUU2mL2O6TEJ9axLkHUp5h5SGlbzDcQe9b4sVik3mrgJBg4qwVomVqhsCtu8qunsDRbpBO4BusDrodYOqEEAiO5ZlIl-UIVgUJnz-H3L4lmTt8mkHPVNwvPY1h1SGbHhxZ9mX6IEe76_Qxny2ELvoXrScp-VsD63742CvHl8_AQns_wo
linkProvider	Elsevier
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Induction+of+apoptosis+by+a+novel+copper-based+anticancer+compound%2C+casiopeina+II%2C+in+L1210+murine+leukaemia+and+CH1+human+ovarian+carcinoma+cells&rft.jtitle=Toxicology+in+vitro&rft.au=De+Vizcaya-Ruiz%2C+A&rft.au=Rivero-Muller%2C+A&rft.au=Ruiz-Ramirez%2C+L&rft.au=Kass%2C+G+E&rft.date=2000-02-01&rft.issn=0887-2333&rft.volume=14&rft.issue=1&rft.spage=1&rft_id=info:doi/10.1016%2Fs0887-2333%2899%2900082-x&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0887-2333&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0887-2333&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0887-2333&client=summon